share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股SEC公告 ·  2024/08/20 04:19

Moomoo AI 已提取核心信息

Core Scientific has completed its private offering of $460 million 3.00% Convertible Senior Notes due 2029, including the full exercise of the initial purchasers' $60 million option. The notes will accrue interest at 3.00% per annum, payable semi-annually, with maturity on September 1, 2029. The initial conversion rate is 90.9256 shares per $1,000 principal amount, representing a conversion price of approximately $11.00 per share.The company will use approximately $61.2 million of the net proceeds to repay outstanding loans under its credit agreement and $150 million to redeem all outstanding 12.50% Secured Notes due 2028. The remaining proceeds will be used for general corporate purposes, including working capital, operating expenses, capital expenditures, and potential acquisitions.The notes include provisions for early conversion under specific circumstances and redemption options after September 7, 2027, subject to certain conditions. Core Scientific can settle conversions through cash, common stock, or a combination thereof at its discretion. The notes were offered to qualified institutional buyers under Rule 144A of the Securities Act.
Core Scientific has completed its private offering of $460 million 3.00% Convertible Senior Notes due 2029, including the full exercise of the initial purchasers' $60 million option. The notes will accrue interest at 3.00% per annum, payable semi-annually, with maturity on September 1, 2029. The initial conversion rate is 90.9256 shares per $1,000 principal amount, representing a conversion price of approximately $11.00 per share.The company will use approximately $61.2 million of the net proceeds to repay outstanding loans under its credit agreement and $150 million to redeem all outstanding 12.50% Secured Notes due 2028. The remaining proceeds will be used for general corporate purposes, including working capital, operating expenses, capital expenditures, and potential acquisitions.The notes include provisions for early conversion under specific circumstances and redemption options after September 7, 2027, subject to certain conditions. Core Scientific can settle conversions through cash, common stock, or a combination thereof at its discretion. The notes were offered to qualified institutional buyers under Rule 144A of the Securities Act.
Core Scientific已经完成了46000万美元的3.00%可转换高级票据的私募发行，包含初始购买者6000万美元期权的完整行使。该票据将按每年3.00%的利率计息，按半年支付，到期日为2029年9月1日。初始转换比率为每1000美元票面金额90.9256股，相当于每股大约11.00美元的转换价格。公司将使用约6120万美元的净收益偿还其信贷协议下的未偿贷款，15000万美元用于赎回所有到期2028年的12.50%担保票据。剩余收益将用于一般企业用途，包括运营资金、营业费用、资本支出及潜在收购。该票据包含在特定情况下提前转换的条款，且在2027年9月7日后有赎回选项，受某些条件的限制。Core Scientific可以按其自行决定通过现金、普通股票或两者组合来结算转换。该票据根据《证券法》第144A条款向合格机构买家提供。
Core Scientific已经完成了46000万美元的3.00%可转换高级票据的私募发行，包含初始购买者6000万美元期权的完整行使。该票据将按每年3.00%的利率计息，按半年支付，到期日为2029年9月1日。初始转换比率为每1000美元票面金额90.9256股，相当于每股大约11.00美元的转换价格。公司将使用约6120万美元的净收益偿还其信贷协议下的未偿贷款，15000万美元用于赎回所有到期2028年的12.50%担保票据。剩余收益将用于一般企业用途，包括运营资金、营业费用、资本支出及潜在收购。该票据包含在特定情况下提前转换的条款，且在2027年9月7日后有赎回选项，受某些条件的限制。Core Scientific可以按其自行决定通过现金、普通股票或两者组合来结算转换。该票据根据《证券法》第144A条款向合格机构买家提供。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    HUB Cyber Security
    HUBC
    -- 0.7249
    Gorilla Technology
    GRRR
    -- 30.280
    CISO Global
    CISO
    -- 1.1300
    Yext Inc
    YEXT
    -- 6.800
    ODDITY Tech
    ODD
    -- 47.620
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    中概股集体大涨！2025年中国资产前景如何？
    近期，Goldman Sachs、Morgan Stanley、Appaloosa LP等多家机构唱好中国资产。 $阿里巴巴 (BABA.US)$ 、 $京东 (JD.US)$ 、 $富途控股 (FUTU.US)$ 等中概股价格飙升，市场情绪火热。 🎙️讨论： Deepseek 展开
    中国股票的疯狂反弹暂停？华尔街仍在大举押注热门股票